Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Jan 22 2025

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-jan-22-2025-4

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated January 22, 2025, titled "Zydus announces USFDA Orphan Drug Designation to Usnoflast for the treatment of Amyotrophic Lateral Sclerosis (ALS)".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases